BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 5, 2011
View Archived Issues
Novel PAK inhibitors reported by Afraxis
Read More
WARF scientists present novel vitamin D receptor ligands
Read More
Novel hepatocyte growth factor receptor inhibitors designed
Read More
SYL-1001 confers analgesia in animal model of ocular pain
Read More
Hutchison MediPharma presents preclinical data on new small-molecule anticancer agents
Read More
New MAb targeting anti-Muellerian hormone type-2 receptor suppresses ovarian tumors in vivo
Read More
BiTE antibody MT-112/BAY-2010112 targets prostate cancer
Read More
Glaucoma candidate ATS-907 shows promising efficacy and safety profile
Read More
Immunetics receives NIH grant for clinical trials of immunoblot test for Chagas' disease
Read More
Debiopharm and Yale University enter licensing agreement for Debio-1036
Read More
Akebia Therapeutics completes phase IIa pilot study of AKB-6548 for anemia
Read More
New inhibitors of lysine-specific histone demethylase 1A and/or MAO-B claimed
Read More
Aquaporin-9 expression demonstrated in malignant glioma biopsies
Read More
Novel estrogen receptor beta ligands prepared at Karo Bio
Read More
Northwest Biotherapeutics recruits additional patients in DCVax-Brain trial
Read More
Almirall and Nycomed enter co-branding agreement for roflumilast in Spain
Read More
Sanofi-aventis and Medicines for Malaria Venture enter alliance to develop malaria treatments
Read More
Allergan and Molecular Partners sign license agreement for MP-0112 in ophthalmic indications
Read More
Pharming and Santarus amend protocol for phase III Rhucin study
Read More
Mologen expands inclusion criteria for pivotal study of MGN-1703 in colorectal cancer
Read More
Savient Pharmaceuticals files MAA with the EMA for Krystexxa in chronic gout
Read More
PharmaGap provides update on liposomal delivery formulations of GAP-107B8
Read More
Enrollment in KAEL-GemVax's phase III pancreatic cancer vaccine trial exceeds 1,000 patients
Read More